triamterene and hydrochlorothiazide (60505-2656)

Drug Facts

Product Profile

Brand Name triamterene and hydrochlorothiazide

Generic Name triamterene and hydrochlorothiazide

Labeler apotex corp.

Dosage Form TABLET

Routes

ORAL

Active Ingredients

hydrochlorothiazide 25 mg/1, triamterene 37.5 mg/1

Manufacturer

Apotex Corp.

Identifiers & Regulatory

Product NDC 60505-2656

Product ID 60505-2656_2b178a53-cddb-a0e3-2eb7-752e47edc56a

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA071251

Listing Expiration 2027-12-31

Marketing Start 2009-09-21

Pharmacologic Class

Established (EPC)

thiazide diuretic [epc] potassium-sparing diuretic [epc]

Chemical Structure

thiazides [cs]

Physiologic Effect

increased diuresis [pe] decreased renal k+ excretion [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 605052656

Hyphenated Format 60505-2656

Supplemental Identifiers

RxCUI

310812 310818

UPC

0360505265619 0360505265718

UNII

0J48LPH2TH WS821Z52LQ

NUI

N0000175359 N0000175419 M0471776 N0000008859 N0000175418

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name triamterene and hydrochlorothiazide (source: ndc)

Generic Name triamterene and hydrochlorothiazide (source: ndc)

Application Number ANDA071251 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

25 mg/1
37.5 mg/1

source: ndc

Packaging

100 TABLET in 1 BOTTLE (60505-2656-1)
500 TABLET in 1 BOTTLE (60505-2656-5)
6500 TABLET in 1 BOTTLE (60505-2656-7)

source: ndc

Packages (3)

60505-2656-1 100 TABLET in 1 BOTTLE (60505-2656-1) 60505-2656-5 500 TABLET in 1 BOTTLE (60505-2656-5) 60505-2656-7 6500 TABLET in 1 BOTTLE (60505-2656-7)

Ingredients (2)

hydrochlorothiazide (25 mg/1) triamterene (37.5 mg/1)

Linked Drug Pages (1)

Triamterene and Hydrochlorothiazide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "2b178a53-cddb-a0e3-2eb7-752e47edc56a", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776", "N0000008859", "N0000175418"], "upc": ["0360505265619", "0360505265718"], "unii": ["0J48LPH2TH", "WS821Z52LQ"], "rxcui": ["310812", "310818"], "spl_set_id": ["bd6c3495-ec70-908b-482a-a979506659e9"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]", "Decreased Renal K+ Excretion [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Potassium-sparing Diuretic [EPC]"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (60505-2656-1)", "package_ndc": "60505-2656-1", "marketing_start_date": "20090921"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (60505-2656-5)", "package_ndc": "60505-2656-5", "marketing_start_date": "20090921"}, {"sample": false, "description": "6500 TABLET in 1 BOTTLE (60505-2656-7)", "package_ndc": "60505-2656-7", "marketing_start_date": "20090921"}], "brand_name": "Triamterene and Hydrochlorothiazide", "product_id": "60505-2656_2b178a53-cddb-a0e3-2eb7-752e47edc56a", "dosage_form": "TABLET", "pharm_class": ["Decreased Renal K+ Excretion [PE]", "Increased Diuresis [PE]", "Increased Diuresis [PE]", "Potassium-sparing Diuretic [EPC]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "60505-2656", "generic_name": "Triamterene and Hydrochlorothiazide", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Triamterene and Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "25 mg/1"}, {"name": "TRIAMTERENE", "strength": "37.5 mg/1"}], "application_number": "ANDA071251", "marketing_category": "ANDA", "marketing_start_date": "20090921", "listing_expiration_date": "20271231"}